Deletion of the zinc-binding motif of CD13/aminopeptidase N molecules results in loss of epitopes that mediate binding of inhibitory antibodies.
暂无分享,去创建一个
[1] D. Marguet,et al. Evidence that thymocyte-activating molecule is mouse CD26 (dipeptidyl peptidase IV). , 1991, Journal of immunology.
[2] M. Cooper,et al. Aminopeptidase A activity of the murine B-lymphocyte differentiation antigen BP-1/6C3. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[3] E. Danielsen. Perturbation of intestinal microvillar enzyme biosynthesis by amino acid analogs. Evidence that dimerization is required for the transport of aminopeptidase N out of the endoplasmic reticulum. , 1990, The Journal of biological chemistry.
[4] B. Vallee,et al. Zinc coordination, function, and structure of zinc enzymes and other proteins. , 1990, Biochemistry.
[5] G. Air,et al. Epitopes on protein antigens: Misconceptions and realities , 1990, Cell.
[6] M. Hegen,et al. The T cell triggering molecule Tp103 is associated with dipeptidyl aminopeptidase IV activity. , 1990, Journal of immunology.
[7] A. Feller,et al. CD26 Antigen is a Surface Dipeptidyl Peptidase IV (DPPIV) as Characterized by Monoclonal Antibodies Clone Til‐19‐4‐7 and 4EL1C7 , 1990, Scandinavian journal of immunology.
[8] G. Air,et al. Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[9] R. Ashmun,et al. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells , 1990 .
[10] Danielsen Em. Biosynthesis of intestinal microvillar proteins. Dimerization of aminopeptidase N and lactase-phlorizin hydrolase. , 1990 .
[11] E. Danielsen. Biosynthesis of intestinal microvillar proteins. Dimerization of aminopeptidase N and lactase-phlorizin hydrolase. , 1990, Biochemistry.
[12] I. Weissman,et al. The early B lineage antigen BP-1 and the transformation-associated antigen 6C3 are on the same molecule. , 1989, Journal of immunology.
[13] B. Vallee,et al. Short and long spacer sequences and other structural features of zinc binding sites in zinc enzymes , 1989, FEBS letters.
[14] R. Ashmun,et al. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. , 1989, The Journal of clinical investigation.
[15] C. Jongeneel,et al. Common acute lymphoblastic leukemia antigen expressed on leukemia and melanoma cell lines has neutral endopeptidase activity. , 1989, The Journal of clinical investigation.
[16] J. Engberg,et al. Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA , 1988, FEBS letters.
[17] R. Mcinnes,et al. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase , 1988, The Journal of experimental medicine.
[18] 山上 正彦. 非白血病患者骨髄中に存在するCommon Acute Lymphoblastic Leukemia Antigen(CALLA)陽性リンパ球様細胞の性状に関する研究 , 1988 .
[19] B. Roques,et al. Exploration of the catalytic site of endopeptidase 24.11 by site‐directed mutagenesis Histidine residues 583 and 587 are essential for catalysis , 1988, FEBS letters.
[20] B. Roques,et al. Expression of neutral endopeptidase (enkephalinase) in heterologous COS-1 cells. Characterization of the recombinant enzyme and evidence for a glutamic acid residue at the active site. , 1988, The Journal of biological chemistry.
[21] J. Talmadge,et al. Immunomodulatory and therapeutic properties of bestatin in mice. , 1986, Cancer research.
[22] G. Semenza. Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli. , 1986, Annual review of cell biology.
[23] A. Turner,et al. The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase N. , 1985, The Biochemical journal.
[24] A. Turner,et al. Are there neuropeptide-specific peptidases? , 1985, Biochemical pharmacology.
[25] M. Roussel,et al. Transfer and expression of the gene encoding a human myeloid membrane antigen (gp150). , 1985, The Journal of clinical investigation.
[26] C. Cepko,et al. Construction and applications of a highly transmissible murine retrovirus shuttle vector , 1984, Cell.
[27] H. Sedlacek,et al. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. , 1983, Cancer research.
[28] H. Blomgren,et al. Increased granulocyte phagocytosis after oral administration of bestatin, a new immunomodulator. , 1982, Journal of clinical & laboratory immunology.
[29] W. Müller,et al. Activation of DNA metabolism in T-cells by bestatin. , 1979, Biochemical pharmacology.
[30] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[31] T. Aoyagi,et al. Bestatin, a new specific inhibitor of aminopeptidases, enhances activation of small lymphocytes by concanavalin A. , 1977, Biochemical and biophysical research communications.